CYP3A5
Showing 1 - 25 of >10,000
Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Warsaw (Tacrolimus, Unbound tacrolimus
Recruiting
- Immunosuppression
- +6 more
- Tacrolimus
- +2 more
-
Warsaw, PolandDepartment of General and Transplant Surgery, Medical University
Apr 14, 2022
Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Singapore (Tacrolimus)
Recruiting
- Kidney Transplant Rejection
- Kidney Transplant; Complications
-
Singapore, SingaporeSingapore General Hospital
Dec 5, 2021
Donor on Tacrolimus Concentration in Liver Transplant
Completed
- Liver Transplantation
-
Taipei, Taiwan
- +1 more
Aug 4, 2021
Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and
Enrolling by invitation
- Pregnancy Related
-
Chicago, IllinoisNorthwestern University Asher Center for the Study and Treatment
Aug 15, 2022
DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic
Completed
- Anticoagulants and Bleeding Disorders
- CYP3A4/5 and P-gp phenotyping
- CYP3A4/5 and P-gp genotyping
-
Geneva, SwitzerlandHUG
Sep 29, 2021
Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid
Completed
- Drug-Drug Interaction
- ITF2357 Givinostat 10mg/mL
- +4 more
-
Porto, PortugalHospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022
COPD Trial in Antwerp (CHF6001 DPI, Itraconazole)
Completed
- Chronic Obstructive Pulmonary Disease
- CHF6001 DPI
- Itraconazole
-
Antwerp, BelgiumSGS Life Sciences - Clinical Pharmacology Unit Antwerpen
May 4, 2021
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- +3 more
-
Tempe, ArizonaCelerion - Tempe, AZ Site
Aug 9, 2023
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Healthy Volunteers Trial in Seoul (Midazolam, Clarithromycin, Grapefruit juice)
Completed
- Healthy Volunteers
- Midazolam
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Healthy Volunteers Trial (Brensocatib, Clarithromycin)
Not yet recruiting
- Healthy Volunteers
- (no location specified)
Jul 19, 2023
Health Volunteers Trial in Miami (CTP-543, Fluconazole)
Recruiting
- Health Volunteers
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Jul 26, 2022
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Healthy Trial (Sildenafil, Erythromycin, Itraconazole)
Completed
- Healthy
- Sildenafil
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Healthy Subjects, Drug-drug Interaction, Pharmacokinetics Trial in San Antonio (Efavirenz, Quizartinib)
Completed
- Healthy Subjects
- +3 more
-
San Antonio, TexasWorldwide Clinical Trials
Jun 3, 2022
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023